Syndivia Competitors and Similar CompaniesClear all
Syndivia's competitors and similar companies include Immunochina and Normunity.
 Syndivia Syndivia is a biotechnology company that develops treatment solutions to cancer patients by leveraging microenvironment and anatomical hallmarks for tumors. |  Immunochina Immunochina is a company that specializes in applying CAR-T technology and gene cell drugs to the treatment of malignant tumors. |  Normunity Normunity is a biotechnology company that specializes in immuno-oncology medicine creation. | |
Founding Date | Founding Date 2014 | Founding Date 2015 | Founding Date 2021 |
Type | Type Private | Type Private | Type Private |
Tags | |||
Locations | Locations Illkirch-Graffenstaden, FR HQ Strasbourg, FR | Locations CN HQ | Locations West Haven, US HQ Boston, US |
Employees | Employees 6 | Employees 205% increase | Employees 225% increase |
Funding | |||
Latest funding round | Latest funding round $ 2.3m (about 6 years ago) | Latest funding round $ 20.6m (over 7 years ago) | Latest funding round $ 65m (over 3 years ago) |
Total funding raised | Total funding raised $ 3.9m | Total funding raised $ 28.1m | Total funding raised $ 65m |
For sources of this data, please see the company profile
View Company Profiles
Immunochina
HQ
CN
Employees
20↑ 5% increase
Immunochina is a company that specializes in applying CAR-T technology and gene cell drugs to the treatment of malignant tumors.
View companyNormunity
HQ
West Haven, US
Employees
22↑ 5% increase
Normunity is a biotechnology company that specializes in immuno-oncology medicine creation.
View company